Modelportefølje: Revenios vægt stiger i porteføljen som følge af fortegningsrettsemissionen

REG1VResearch28.09.2026, 09.11

Automatisk oversættelse: Oprindeligt udgivet på finsk 28.9.2026, 07.11 GMT. Giv feedback her.

Modelporteføljen udnytter alle sine tegningsrettigheder i Revenio og købte derudover 471 rettigheder, som vi bruger til at tegne i alt 756 nye aktier i selskabets fortegningsrettsemission til en stykpris på 6,19 EUR. Vores samlede investering er cirka 5 600 EUR. Vi gennemførte transaktionerne mandag den 28. september, da tegningsperioden og handlen med tegningsrettigheder begyndte. Efter emissionen er Revenios vægt i modelporteføljen cirka 8 % og kontantandelen cirka 7 %.

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Key Estimate Figures23.09

	2025	26e	27e
Revenue	109.7	200.2	269.6
growth-%	6.0 %	82.5 %	34.7 %
EBIT (adj.)	26.5	32.2	44.8
EBIT-% (adj.)	24.2 %	16.1 %	16.6 %
EPS (adj.)	0.58	0.67	0.67
Dividend	0.00	0.00	0.00
Dividend %
P/E (adj.)	33.0	16.0	15.8
EV/EBITDA	16.7	19.2	11.0

Forum discussions

Nyt meni merkitseminen läpi kun rahat tuli T+2 pv ajassa OSTin hoitotilille. Se ei siis riitä, että OSTilta myy osakkeita ja saa varat käytett...

1 hour ago

by palse

Jahas, taisi Caravelle saada eilen hankittua haluamansa määrän merkkareita ja nyt niiden kurssi sukeltaa.

2 hours ago

by Kryptoniitti

I just realized that Revenio’s rights issue presentation webcast was today. A couple of approvals and registration are required before you can...

15 hours ago

by NukkeNukuttaja

“We used to have a very highly profitable company → well, now it’s a lot less profitable company Return on capital was high → well, now it’s...

18 hours ago

by Optis

Yesterday’s arbitrage of about €0.20/share melted away today. According to Nordnet’s broker statistics, all the big net buyers today were American...

19 hours ago

by Juurikki

I think so too, and yes, subscription rights can only be bought for a traditional osakeopstitiili (AOT) [share savings account]. Let’s see if...

22 hours ago

by palse

Of course, you can subscribe to new issues with an equity savings account (OST), but you can’t buy subscription rights (merkkari) because you...

22 hours ago

by FanTom

Modelportefølje: Revenios vægt stiger i porteføljen som følge af fortegningsrettsemissionen

REG1VResearch28.09.2026, 09.11

Juha Kinnunen, Atte Riikola, Rauli Juva

Discuss

Automatisk oversættelse: Oprindeligt udgivet på finsk 28.9.2026, 07.11 GMT. Giv feedback her.

Key Estimate Figures23.09

	2025	26e	27e
Revenue	109.7	200.2	269.6
growth-%	6.0 %	82.5 %	34.7 %
EBIT (adj.)	26.5	32.2	44.8
EBIT-% (adj.)	24.2 %	16.1 %	16.6 %
EPS (adj.)	0.58	0.67	0.67
Dividend	0.00	0.00	0.00
Dividend %
P/E (adj.)	33.0	16.0	15.8
EV/EBITDA	16.7	19.2	11.0